that can provide advice and a range of perspectives and expertise from academic institutions, industry and government bodies, covering the entirety of the pipeline and supply chain.
Life Sciences Queensland (LSQ) has established the BioManufacturing Alliance (BMA) as a partnership linking some of the state’s leading research institutions and commercial interests to increase collaboration across the sector and help Queensland become a globally competitive biomanufacturing hub.
To establish Queensland as an integrated precinct that delivers innovative
Australian-made life-saving therapies, biomanufacturing self-sufficiency, and creates and sustains high-value jobs.
To bring together Queensland's capabilities across biotherapeutics and vaccines to develop
end-to-end biomanufacturing capability and capacity. This will capture the value of Australian innovation, and provide a platform to inform decisions on future workforce training and infrastructure requirements.
To provide a platform to inform decisions on future workforce training and infrastructure requirements
to underpin and accelerate the creation of a future-ready workforce and attract investment to the state.